All Stories

  1. Parallel Multi-Scale Deep Supervision Net for Hand Key Point Detection
  2. A word in the hand is worth two in the push: Comparing vocal and manual responses to the arrow-word Stroop task
  3. Association of tongue, handgrip, and pinch strength with blood-based phosphorylated-tau 181 in cognitively healthy older adults
  4. Modifiable Dementia Risk Factors by Country of Birth among South Asian Migrants Aged 50 or Older in Tasmania, Australia
  5. Association of chronic pain and analgesic use with the risks of Parkinson’s and Alzheimer’s disease
  6. The Tasmania-London protocol to detect isolated rapid eye movement sleep behavior disorder using home-based video-polysomnography
  7. Advice to people with Parkinson's in my clinic: How to manage running-induced dystonia
  8. Gait in Older People with Cognitive Impairments During Rhythmic Auditory Cueing: A Scoping Review
  9. Chronic Pain in Parkinson’s Disease: Prevalence, Sex Differences, Regional Anatomy and Comorbidities
  10. Are We Asking the Right Questions? Sex Specificity of Dream Characteristics in Probable Rapid Eye Movement Sleep Behavior Disorder
  11. Evaluating the impact of human expertise in human-centered AI: A case study on finger-tapping video analysis for dementia detection
  12. Falls in people with Alzheimer’s disease: Exploring the role of inhibitory control
  13. Digitised hand movement and plasma NfL are complementary biomarkers of the dementia continuum
  14. Modifiable dementia risk factors by country of birth among South Asian migrants aged 50 or older in Tasmania, Australia
  15. A comparison of modifiable risk factors for dementia among South Asian migrants and non-migrants aged 50 or older in Tasmania, Australia
  16. Physical activity and blood‐based biomarkers of neurodegeneration in community dwelling Australians from ISLAND (Island Study Linking Ageing and Neurodegenerative Disease)
  17. Self-testing for symptoms and signs of prodromal alpha-synucleinopathies: results from the Tasmanian ISLAND Sleep Study
  18. Rapid repetitive syllable sounds associate with episodic memory, executive function, and working memory in cognitively healthy and subjectively impaired older adults
  19. Presymptomatic blood tests to detect neurodegeneration: Perceptions of potential consumers across the life course
  20. The Tasmania-London (TASLON) 3-step home-based video-polysomnography approach to detect iRBD in the community: protocol and preliminary results
  21. Impact of Plasma pTau181 Levels on Clinician Diagnostic Confidence and Management in Memory and Cognition Clinics: A Multi-site Before-and-After Study
  22. Stepping and tapping: combining motor tasks improves cognitive classification
  23. Keeping an eye on Parkinson’s disease: color vision and outer retinal thickness as simple and non-invasive biomarkers
  24. Deep Learning Analysis of Figure Copying Tasks for Parkinson’s Disease Detection with GAN-Based Data Augmentation
  25. Post-diagnostic support in Australia: Perspectives of people recently diagnosed with dementia and their carers
  26. Handwriting patterns in Isolated Rapid Eye Movement Sleep Behaviour Disorder
  27. Mild Cognitive Impairment: Far from “Mild,” but Is Deep Brain Stimulation the Solution?
  28. Computer Vision in Clinical Neurology
  29. Feasibility of computerized motor, cognitive and speech tests in the home: Analysis of TAS Test in 2,300 older adults
  30. Falls in people with Alzheimer’s Disease: Exploring the role of inhibitory control
  31. Chronic Pain in Parkinson’s Disease: Prevalence, Sex Differences, Regional Anatomy and Comorbidities
  32. Development of a diagnostic checklist to identify functional cognitive disorder versus other neurocognitive disorders
  33. Developing, implementing, and evaluating the first national Memory and Cognition Clinic Guidelines in Australia
  34. ISLAND Campus: a fee-free formal university educational intervention in mid- to later-life to reduce modifiable risk factors for dementia and improve cognition
  35. Associations Between Brain Structure and Dual Decline in Gait and Cognition
  36. Immediate post‐diagnostic support for people with dementia and thier care partners: Scoping literature review
  37. Impact of free later life formal university education on longitudinal modifiable risk factors, cognition and plasma phosphorylated tau 181
  38. Rural‐urban improvements in modifiable risk factors across Tasmania from an online, public health dementia risk reduction initiative: data from ISLAND (Island Study Linking Ageing and Neurodegenerative Disease)
  39. Tapping into a new hand‐motor biomarker of the dementia continuum ‐ integration and validation in a cognitive clinic
  40. Unsupervised online reaction time test improves estimation of cognitive function in a large sample of cognitively‐asymptomatic older adults
  41. Using TAS Test online hand‐tapping tests to detect cognitive decline in a large community cohort of older Australians
  42. Chronic Musculoskeletal Pain and Risk of Incident Parkinson's Disease: A 13‐Year Longitudinal Study
  43. Validation of computer vision technology for analyzing bradykinesia in outpatient clinic videos of people with Parkinson's disease
  44. Associations between brain structure and dual decline in gait and cognition
  45. P027 Dream characteristics are sex-specific in REM Sleep Behaviour Disorder and healthy older adults
  46. Smartphone automated motor and speech analysis for early detection of Alzheimer's disease and Parkinson's disease: Validation of TapTalk across 20 different devices
  47. Practical Ultrasound
  48. Deep learning of Parkinson's movement from video, without human-defined measures
  49. Hand Motor Dysfunction Is Associated with Both Subjective and Objective Cognitive Impairment across the Dementia Continuum
  50. Validation and application of computer vision algorithms for video-based tremor analysis
  51. The Parkinson's Puzzle Box
  52. Widening the Phenotype of Fragile‐X Tremor Ataxia Syndrome in Females: Spasmodic Dysphonia in Two Patients
  53. Perspectives on the diagnosis and management of functional cognitive disorder: An international Delphi study
  54. Identifying and Managing Drug Induced Parkinsonism: The Role of Neuroscience Nurses
  55. Development of a smartphone screening test for preclinical Alzheimer’s disease and validation across the dementia continuum
  56. Modifiable dementia risk factors and AT(N) biomarkers: findings from the EPAD cohort
  57. Transdermal Rotigotine at End-of-Life for Parkinson's Disease: Association With Measures of Distress
  58. The effect of dyskinesia on postural control, balance, gait, and fall risk in people with Parkinson’s disease: a systematic review protocol
  59. Brief webcam test of hand movements predicts episodic memory, executive function, and working memory in a community sample of cognitively asymptomatic older adults
  60. Parallel scale de-blur net for sharpening video images for remote clinical assessment of hand movements
  61. Rapid-Motion-Track: Markerless tracking of fast human motion with deep learning
  62. Development of a smartphone screening test for preclinical Alzheimer's disease and validation across the dementia continuum
  63. Visual perceptive deep learning for smartphone video-based tremor analysis: VIPER-Tremor
  64. Clinical validation of TAS Test automated hand motor analysis to discriminate subjective cognitive decline, mild cognitive impairment and dementia in a multidisciplinary cognitive clinic
  65. Clinical validation of TAS Test automated hand motor analysis to discriminate subjective cognitive decline, mild cognitive impairment and dementia in a multidisciplinary cognitive clinic
  66. Identifying preclinical Alzheimer’s disease in the community with brief automated hand movement analysis: validation against plasma ptau181 and asymptomatic episodic memory decline
  67. Identifying preclinical Alzheimer’s disease in the community with brief automated hand movement analysis: validation against plasma ptau181 and asymptomatic episodic memory decline
  68. Isolated REM sleep behaviour disorder in the Tasmanian ISLAND Sleep Study: prevalence and profiles of prodromal dementia
  69. Modifiable dementia risk factor associations with AT(N) biomarkers: Findings from the European Prevention of Alzheimer’s Dementia study
  70. Plasma phosphorylated tau 181 and modifiable risk factors for dementia in a large scale cohort of Australian older adults
  71. Tasmanian ISLAND Sleep Study: prodromal neurodegenerative disease (iRBD) is associated with subjective reports of daytime sleepiness and poor sleep quality
  72. Isolated rapid eye movement sleep behaviour disorder (iRBD) in the Island Study Linking Ageing and Neurodegenerative Disease (ISLAND) Sleep Study: protocol and baseline characteristics
  73. Enhancing post-diagnostic care in Australian memory clinics: Health professionals’ insights into current practices, barriers and facilitators, and desirable support
  74. Brain Networks Involved in Sensory Perception in Parkinson’s Disease: A Scoping Review
  75. Modifiable risk factors for dementia, cognition, and plasma phosphorylated tau 181 in a large-scale cohort of Australian older adults
  76. Current evidence on the association of tongue strength with cognitive decline in older adults and the known risk factors of frailty, sarcopenia and nutritional health: a scoping review protocol
  77. An online, public health framework supporting behaviour change to reduce dementia risk: interim results from the ISLAND study linking ageing and neurodegenerative disease
  78. Pushing through the Barriers: Peer Advice to Increase Physical Activity and Reduce Dementia Risk from Participants in a Massive Open Online Alzheimer's Focused Course
  79. Does serum neurofilament light help predict accelerated cognitive ageing in unimpaired older adults?
  80. 15 TAS test clinical validation: automated hand movement analysis helps discriminate subjective cognitive decline, mild cognitive impairment and dementia
  81. 2692 The future is in our hands: screening for preclinical alzheimer’s disease at home using automated analysis of hand movements
  82. A new one‐stop interdisciplinary cognitive clinic model tackles rural health inequality and halves the time to diagnosis: Benchmarked against a national dementia registry
  83. Estimating presymptomatic episodic memory impairment using simple hand movement tests: A cross‐sectional study of a large sample of older adults
  84. Contactless hand tremor amplitude measurement using smartphones: development and pilot evaluation
  85. Multimodal learning of clinically accessible tests to aid diagnosis of neurodegenerative disorders: a scoping review
  86. Investigating the associations between upper limb motor function and cognitive impairment: a scoping review
  87. Parkinsonian Hand or Clinician’s Eye? Finger Tap Bradykinesia Interrater Reliability for 21 Movement Disorder Experts
  88. Instruments measuring change in cognitive function in multiple sclerosis: A systematic review
  89. Functional neurological disorder is a feminist issue
  90. An online, public health framework supporting behaviour change to reduce dementia risk: interim results from the Island Study Linking Ageing and Neurodegenerative Disease
  91. Sex-Specific Protective Effects of Cognitive Reserve on Age-Related Cognitive Decline
  92. Clinicians' implicit and explicit attitudes about the legitimacy of functional neurological disorders correlate with referral decisions
  93. Of Mice and Pose: 2D Mouse Pose Estimation from Unlabelled Data and Synthetic Prior
  94. REM sleep behaviour disorder: the importance of early identification in primary care
  95. Real-time automated detection of older adults' hand gestures in home and clinical settings
  96. Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease
  97. Differences in clinical manifestations of late-onset, compared to earlier-onset essential tremor: A scoping review
  98. Moving towards intelligent telemedicine: Computer vision measurement of human movement
  99. The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer’s disease and estimate 5-year risks of cognitive decline and dementia
  100. Systemic lupus erythematosus-induced intracranial hypertension: rare but important
  101. Challenges of Incorporating Digital Health Technology Outcomes in a Clinical Trial: Experiences from PD STAT
  102. Geste Antagoniste Effects on Motor Performance in Dystonia—A Kinematic Study
  103. Diagnostic Accuracy of the Overlapping Infinity Loops, Wire Cube, and Clock Drawing Tests in Subjective Cognitive Decline, Mild Cognitive Impairment and Dementia
  104. New horizons in late-onset essential tremor: a pre-cognitive biomarker of dementia?
  105. Isolated REM sleep behaviour disorder: current diagnostic procedures and emerging new technologies
  106. To the emergency room and back again: Circular healthcare pathways for acute functional neurological disorders
  107. 248  Tremor frequency can be measured using smartphone video
  108. Increased Knowledge of Adult-Onset Dystonia Amongst Medical Students via Brief Video Education: A Systematic Review and Cohort Study
  109. Island Study Linking Aging and Neurodegenerative Disease (ISLAND) Targeting Dementia Risk Reduction: Protocol for a Prospective Web-Based Cohort Study
  110. Applications of artificial intelligence to aid early detection of dementia: A scoping review on current capabilities and future directions
  111. Truth, hope and the disclosure of a dementia diagnosis: A scoping review of the ethical considerations from the perspective of the person, carer and clinician
  112. Are tomorrow’s doctors prepared to prevent dementia? A cross-sectional study of Tasmanian medical students’ knowledge of dementia risk factors
  113. Evolutionary Design of Reduced Precision Levodopa-Induced Dyskinesia Classifiers
  114. Automated analysis of propositional idea density in older adults
  115. TasTest: Moving towards a digital screening test for pre‐clinical Alzheimer’s disease
  116. Island Study Linking Aging and Neurodegenerative Disease (ISLAND) Targeting Dementia Risk Reduction: Protocol for a Prospective Web-Based Cohort Study (Preprint)
  117. Parkinson’s disease diagnosis using convolutional neural networks and figure-copying tasks
  118. Association Between Components of Cognitive Reserve and Serum BDNF in Healthy Older Adults
  119. Hand tremor detection in videos with cluttered background using neural network based approaches
  120. Significant cognitive decline in Parkinson's disease exacerbates the reliance on visual feedback during upper limb reaches
  121. Significant cognitive decline in Parkinson’s disease exacerbates the reliance on visual feedback during upper limb reaches
  122. Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter Audit
  123. An Innovative Personalised Management Program for Older Adults with Parkinson’s Disease: New Concepts and Future Directions
  124. Moving Towards Intelligent Telemedicine: Computer Vision Measurement of Human Movement
  125. Studying at university in later life slows cognitive decline: A long‐term prospective study
  126. Accuracy of Smartphone Video for Contactless Measurement of Hand Tremor Frequency
  127. The Island Study Linking Ageing and Neurodegenerative Disease (ISLAND): A longitudinal public health research program targeting dementia risk reduction
  128. Seeing the unseen: Could Eulerian video magnification aid clinician detection of subclinical Parkinson’s tremor?
  129. Supervised classification of bradykinesia in Parkinson’s disease from smartphone videos
  130. What is it like to live with a functional movement disorder? An interpretative phenomenological analysis of illness experiences from symptom onset to post‐diagnosis
  131. The discerning eye of computer vision: Can it measure Parkinson's finger tap bradykinesia?
  132. Get Parkinson’s medications on time: the Leeds QI project
  133. Time series clustering to examine presence of decrement in Parkinson’s finger-tapping bradykinesia
  134. Oromandibular dystonia: a diagnosis not to miss
  135. A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease: a study protocol for a randomised controll...
  136. Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
  137. Can we reduce the risk of dementia with exercise?
  138. 127 Audit of poor response to botulinum toxin in cervical dystonia
  139. Health at the writing desk of John Ruskin: a study of handwriting and illness
  140. Application of classification for figure copying test in Parkinson's disease diagnosis by using cartesian genetic programming
  141. Multiple myeloma with multiple neurological presentations
  142. Computer vision of smartphone video has potential to detect functional tremor
  143. Supervised Classification of Bradykinesia for Parkinson's Disease Diagnosis from Smartphone Videos
  144. Multiple system atrophy mimicked by multi-organ pathology
  145. Inferring the long duration response to levodopa in Parkinson’s disease
  146. FM2-1 A smartphone camera can detect functional tremor
  147. P68 Activation of the geste antagoniste improves speed of finger tapping in organic and functional dystonia
  148. P66 Should we be screening for depression and quality of life in all patients attending botulinum toxin injection clinics or just those with cervical dystonia?
  149. A smartphone camera reveals an ‘invisible’ Parkinsonian tremor: a potential pre-motor biomarker?
  150. WED 109 Computer vision: a smartphone camera can ‘see’ bradykinesia
  151. 292 Mapping patient pathways for acute functional neurological symptoms
  152. WED 112 Seeing invisible parkinsonian tremor with a smartphone camera
  153. Objective assessment of bradykinesia in Parkinson’s disease using evolutionary algorithms: clinical validation
  154. 131A quality improvement project to improve the care of people with Parkinson’s in a large teaching hospitals trust
  155. Cognitive deficits in Parkinson’s disease: current perspectives
  156. Objective Evaluation of Bradykinesia in Parkinson’s Disease using Evolutionary Algorithms
  157. A New Evolutionary Algorithm-Based Home Monitoring Device for Parkinson’s Dyskinesia
  158. How to use pen and paper tasks to aid tremor diagnosis in the clinic
  159. A History of Dystonia: Ancient to Modern
  160. Lesson of the month 1: Subacute thyroiditis: a rare cause of fever of unknown origin
  161. Lesson of the month 2: Transient reversible amnesia in multiple sclerosis
  162. Going through directional changes
  163. Objective Assessment of Cognitive Impairment in Parkinson’s Disease Using Evolutionary Algorithm
  164. Exploring diagnostic models of Parkinson's disease with multi-objective regression
  165. Functional dystonia and the borderland between neurology and psychiatry: New concepts
  166. Dystonia in a prolific medieval scribe
  167. Using epigenetic networks for the analysis of movement associated with levodopa therapy for Parkinson's disease
  168. Study of levodopa response in Parkinson's disease: Observations on rates of motor progression
  169. A Multi-Objective Approach to Predicting Motor and Cognitive Deficit in Parkinson's Disease Patients
  170. Using Multiobjective Evolutionary Algorithms to Understand Parkinson's Disease
  171. What to do when people with Parkinson's disease cannot take their usual oral medications
  172. Computational approaches for understanding the diagnosis and treatment of Parkinson's disease
  173. Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons?
  174. Cost Effectiveness Analysis of A Device to Monitor Levodopa-Induced Dyskinesia In Parkinson’s Patients
  175. Reply: Essential tremor in ‘The tremulous hand of Worcester’: additional comments
  176. FINGER TAPPING AND COGNITION IN PARKINSON'S
  177. THE RELATIONSHIP BETWEEN CLOCK DRAWING AND COGNITION IN PARKINSON'S
  178. VISUOSPATIAL TESTS TO SCREEN FOR IMPAIRED COGNITION IN PARKINSON'S
  179. What type of tremor did the medieval ‘Tremulous Hand of Worcester’ have?
  180. When myopathy breaks the rules: a late-onset distal presentation
  181. Cognitive impairment in Parkinson's disease
  182. Evolving Classifiers to Recognize the Movement Characteristics of Parkinson's Disease Patients
  183. Classification and characterisation of movement patterns during levodopa therapy for parkinson's disease
  184. Clinically ‘/INS;slight’/INS; bradykinesia is accurately detected using a novel device that requires a one-minute test period
  185. The sequence effect is not a defining characteristic of Parkinson'/INS;s disease
  186. Practical Ultrasound
  187. Palliative care for Parkinson’s disease: A summary of the evidence and future directions
  188. Characterisation of movement disorder in parkinson's disease using evolutionary algorithms
  189. Characterising neurological time series data using biologically motivated networks of coupled discrete maps
  190. Evolving classifiers to inform clinical assessment of Parkinson's disease
  191. Longitudinal study of levodopa in Parkinson's disease: Effects of the advanced disease phase
  192. 103 Computer assisted diagnosis and monitoring of Parkinson's disease
  193. Evolving Computational Dynamical Systems to Recognise Abnormal Human Motor Function
  194. PO.11 How is stroke thrombolysis affecting neurology training?
  195. A practical guide to the differential diagnosis of tremor
  196. A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease
  197. Longitudinal study of the levodopa motor response in Parkinson's disease: Relationship between cognitive decline and motor function
  198. John Ruskin's relapsing encephalopathy
  199. Multi-system complications of hypothermia: a case of recurrent episodic hypothermia with a review of the pathophysiology of hypothermia
  200. Cluster-like headache secondary to trigeminal meningioma
  201. A patient with neuro-Behçet's disease is successfully treated with etanercept: Further evidence for the value of TNFα blockade
  202. Pulmonary artery dissection: an emerging cardiovascular complication in surviving patients with chronic pulmonary hypertension
  203. Editorial
  204. The well-tempered computer
  205. Dorians and Ionians